OptimizeRx Corp. (OPRX) vs Organogenesis Holdings Inc. (ORGO)
A side-by-side comparison of OptimizeRx Corp. and Organogenesis Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
OPRX
OptimizeRx Corp.
$8.81HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ORGO
Organogenesis Holdings Inc.
$1.34HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — OPRX vs ORGO
growth of $100 · dividends reinvested · last 10yOPRX +258.8% (+13.6%/yr)ORGO -86.8% (-18.3%/yr)OPRX compounded faster over this window
Log scale — wide-divergence pair
OPRX ORGO
OPRX vs ORGO: by the numbers
- •ORGO is the larger company ($172M vs $165M market cap).
- •OPRX is profitable (4.66% net margin) while ORGO runs a net loss (-19.76%).
- •OPRX grew revenue faster over the past five years (13.75% vs 1.05% CAGR).
Metrics side by side
Valuation
| Metric | OPRX | ORGO |
|---|---|---|
| P/E ratio | 37.71 | N/A |
| Forward P/E | 9.83 | N/A |
| P/S ratio | 1.68 | 0.38 |
| P/B ratio | 1.26 | 1.16 |
| EV / EBITDA | 10.41 | 216.92 |
| FCF yield | 11.10% | 12.09% |
Profitability
| Metric | OPRX | ORGO |
|---|---|---|
| Gross margin | 63.30% | 67.59% |
| Operating margin | 11.45% | 9.92% |
| Net margin | 4.66% | -19.76% |
| ROE | 3.51% | -31.32% |
| ROIC | 4.92% | -8.34% |
Growth (annualized)
| Metric | OPRX | ORGO |
|---|---|---|
| Revenue CAGR (5Y) | 13.75% | 1.05% |
| FCF CAGR (5Y) | N/A | -5.54% |
| Total return CAGR (5Y) | -36.23% | -37.41% |
Frequently asked
- Which has grown faster, OPRX or ORGO?
- Over the past five years, OPRX grew revenue faster — OPRX at a 13.75% CAGR versus ORGO at 1.05%.
- Is OPRX or ORGO more profitable?
- OPRX runs the higher net margin — OPRX at 4.66% versus ORGO at -19.76%.
- How have OPRX and ORGO total returns compared?
- Over the past 5 years, OPRX delivered -36.23% and ORGO delivered -37.41% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
OptimizeRx P/E ratioOptimizeRx ROEOrganogenesis ROEOptimizeRx operating marginOrganogenesis operating marginOptimizeRx revenue growthOrganogenesis revenue growthOptimizeRx free cash flowOrganogenesis free cash flow
OptimizeRx & Organogenesis appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.